OIS@ASCRS 2017 Videos

Jerry St. Peter, VP & head, ophthalmic business, says the ophthalmology newcomer is making great progress in building broad pipeline to treat eye disease including…

Frederic Guerard, worldwide business franchise head, ophthalmology, explains how the pharmaceutical giant came to make large bets in presbyopia and dry eye. “I’d like to…

Elizabeth Yeu, MD, of Virginia Eye Consultants, updates OIS-TV on advances in presbyopia and dry eye that impact patients the most. She also reveals the…

Tom Frinzi, worldwide president, surgical, Johnson & Johnson Vision, says the cultural fit of Johnson & Johnson and Abbott Medical Optics helped ease the merger…

Eric Donnenfeld, MD, founding partner of OCLI, shares how his practice is incorporating new diagnostics and treatments. “I spend less time diagnosing the disease and…

Perry Sternberg, head of US commercial at Shire, updates OIS-TV on the progress of Shire’s dry eye blockbuster, Xiidra, and its growing ophthalmic pipeline. He…

In this interview, Tom Mitro, COO of Aerie Pharmaceuticals, says the new hires brought on to prepare for commercial sale of Rhopressa bring new life…

Ludwin Monz, PhD, president and CEO of Carl Zeiss Meditec, explains why the ophthalmology leader brought in new senior leadership. He also reviews the company’s…

Alice Epitropoulos, MD, of Ophthalmic Surgeons & Consultants of Ohio, sat down with OIS-TV to explain how Shire, TrueTear and other advances are impacting her…

Michael Lachman, president of EyeQ Research, delivers an update regarding the OIS Index. Given some of the disappointing clinical news in recent months, it’s no…

Monty Montoya, President & CEO, delivered many updates on the company’s new take on corneal care to OIS@ASCRS. The start-up is evaluating tissue, preparing tissue…